INTEGRATED DERMATOLOGY INTRODUCES A NEW INJECTABLE: JUVÉDERM VOLLURE® XC

Introducing a new filler that adds to the Juvéderm® Collection. 

In an effort to provide even more options to meet the growing range of patient needs, Allergan is once again evolving and expanding their hyaluronic acid (HA) dermal filler technology with the launch of JUVÉDERM VOLLURE® XC.

JUVÉDERM VOLLURE® XC was recently approved by the U.S. Food and Drug Administration (FDA) for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds, in adults over the age of 21.2

JUVÉDERM VOLLURE® XC is the first and only hyaluronic acid (HA) dermal filler FDA-approved to last up to 18 months with optimal treatment

 
 
Vollure® XC is the middle child of the Vycross Technology products; rested between Volbella® XC & Voluma® XC.

This product draws in very little water like it’s Vycross cousins, so what you see, is what you get.

It’s ideal for younger patients looking to explore filler + those more mature patients that need to be topped off.”
— Allergan

 

Interested in learning more?